FULGENT GENETICS, INC. Assets, Noncurrent
FULGENT GENETICS, INC. (FLGT) had Assets, Noncurrent of $25.65 million as of 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2017-05-09
- 2017-03-31: Assets, Noncurrent $25.65M.
- 2016-12-31: Assets, Noncurrent $31.90M.
- 2016-09-30: Assets, Noncurrent $5.26M.
- 2015-12-31: Assets, Noncurrent $2.90M.
| Period end | Assets, Noncurrent |
|---|---|
| 2017-03-31 | $25.65M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $31.90M 10-Q · filed 2017-05-09 |
| 2016-09-30 | $5.26M 10-Q · filed 2016-11-14 |
| 2015-12-31 | $2.90M 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |